CG
OREX

Clinton Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Clinton Group’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,857
Closed -$92K – 921
2015
Q2 		$92K Sell
1,857
-599
-24% -$29.7K 0.01% 559
2015
Q1 		$192K Buy
2,456
+648
+36% +$50.7K 0.05% 440
2014
Q4 		$110K Buy
+1,808
New +$110K 0.03% 440